Reducing translational science roadblocks to disability research

Disability is a common and universal human experience. Yet, people with disabilities (PWDs) are in poorer health and have less access to quality healthcare than their non-disabled peers. In fact, the National Institutes of Health’s (NIH) designated PWDs as a health disparities population in 2023. Th...

Full description

Saved in:
Bibliographic Details
Main Authors: Karen Bonuck, Ariel Fishman
Format: Article
Language:English
Published: Cambridge University Press 2025-01-01
Series:Journal of Clinical and Translational Science
Subjects:
Online Access:https://www.cambridge.org/core/product/identifier/S2059866125100733/type/journal_article
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849735893459402752
author Karen Bonuck
Ariel Fishman
author_facet Karen Bonuck
Ariel Fishman
author_sort Karen Bonuck
collection DOAJ
description Disability is a common and universal human experience. Yet, people with disabilities (PWDs) are in poorer health and have less access to quality healthcare than their non-disabled peers. In fact, the National Institutes of Health’s (NIH) designated PWDs as a health disparities population in 2023. This paper illustrates the application of translational science (TS) principles to overcoming roadblocks to reducing PWDs’ health disparities. Part I provides an overview of health disparities among PWDs and the recent designation – situating both within a TS framework. Part II summarizes literature on specific factors that contribute to PWDs’ exclusion from research, how these factors are reflected in background reports that impelled the designation of PWDs as a disparity population, and how the suggested steps to implement the designation reflect TS principles and its research agenda. Part III describes “Reducing Researcher Roadblocks to Including People with Disabilities in Research (D2/R3),” a TS solution to overcoming PWDs exclusion from research. D2/R3 is our institution’s Clinical and Translational Science Award research project – a mixed-methods study that targets research teams’ knowledge, attitudes, biases, and perceptions that contribution to under representation of persons with developmental disabilities in research.
format Article
id doaj-art-7d7d5f3f59d2446480c631bfab35263c
institution DOAJ
issn 2059-8661
language English
publishDate 2025-01-01
publisher Cambridge University Press
record_format Article
series Journal of Clinical and Translational Science
spelling doaj-art-7d7d5f3f59d2446480c631bfab35263c2025-08-20T03:07:26ZengCambridge University PressJournal of Clinical and Translational Science2059-86612025-01-01910.1017/cts.2025.10073Reducing translational science roadblocks to disability researchKaren Bonuck0https://orcid.org/0000-0003-3695-4669Ariel Fishman1https://orcid.org/0000-0002-0317-1169Departments of Family and Social Medicine, and Pediatrics Co-Director, University Center of Excellence in Developmental Disabilities, Institute for Clinical and Translational Research, Albert Einstein College of Medicine- Montefiore Medical Center, Bronx, NY, USADepartment of Epidemiology and Population Health, Institute for Clinical and Translational Research, Albert Einstein College of Medicine-Montefiore Medical Center, Bronx, NY, USADisability is a common and universal human experience. Yet, people with disabilities (PWDs) are in poorer health and have less access to quality healthcare than their non-disabled peers. In fact, the National Institutes of Health’s (NIH) designated PWDs as a health disparities population in 2023. This paper illustrates the application of translational science (TS) principles to overcoming roadblocks to reducing PWDs’ health disparities. Part I provides an overview of health disparities among PWDs and the recent designation – situating both within a TS framework. Part II summarizes literature on specific factors that contribute to PWDs’ exclusion from research, how these factors are reflected in background reports that impelled the designation of PWDs as a disparity population, and how the suggested steps to implement the designation reflect TS principles and its research agenda. Part III describes “Reducing Researcher Roadblocks to Including People with Disabilities in Research (D2/R3),” a TS solution to overcoming PWDs exclusion from research. D2/R3 is our institution’s Clinical and Translational Science Award research project – a mixed-methods study that targets research teams’ knowledge, attitudes, biases, and perceptions that contribution to under representation of persons with developmental disabilities in research.https://www.cambridge.org/core/product/identifier/S2059866125100733/type/journal_articleDisabilityNational Institutes of Health designationhealth disparity populationClinical and Translational Science Awardsdevelopmental disability
spellingShingle Karen Bonuck
Ariel Fishman
Reducing translational science roadblocks to disability research
Journal of Clinical and Translational Science
Disability
National Institutes of Health designation
health disparity population
Clinical and Translational Science Awards
developmental disability
title Reducing translational science roadblocks to disability research
title_full Reducing translational science roadblocks to disability research
title_fullStr Reducing translational science roadblocks to disability research
title_full_unstemmed Reducing translational science roadblocks to disability research
title_short Reducing translational science roadblocks to disability research
title_sort reducing translational science roadblocks to disability research
topic Disability
National Institutes of Health designation
health disparity population
Clinical and Translational Science Awards
developmental disability
url https://www.cambridge.org/core/product/identifier/S2059866125100733/type/journal_article
work_keys_str_mv AT karenbonuck reducingtranslationalscienceroadblockstodisabilityresearch
AT arielfishman reducingtranslationalscienceroadblockstodisabilityresearch